WHO ICTRP trial

The Effect of Nalbuphine on Emergence Agitation in Preschool Children Undergoing…

ChiCTR2500114207 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR2500114207
Public title The Effect of Nalbuphine on Emergence Agitation in Preschool Children Undergoing Otolaryngologic Surgery: A Randomized Controlled Clinical Study
Scientific title The Effect of Nalbuphine on Emergence Agitation in Preschool Children Undergoing Otolaryngologic Surgery: A Randomized Controlled Clinical Study
Primary sponsor SUN YAT-SEN MEMORIAL HOSPITAL
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Interventional study
Phase 4
Countries China
Conditions Emergence agitation
Interventions Nalbuphine Group:A dose of 0.1 mg/kg nalbuphine was administered intravenously 15 to 30 minutes before the end of surgery.;Control Group:An equal volume of normal saline was administered intravenously 15 to 30 minutes before the end of…
Registration date Dec 9, 2025
Target size Nalbuphine Group:40;Control Group:40
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations